Mesogastrium Metastasis in Colon Cancer
Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure
1 other identifier
observational
50
1 country
1
Brief Summary
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2021
CompletedFirst Submitted
Initial submission to the registry
July 20, 2021
CompletedFirst Posted
Study publicly available on registry
July 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 19, 2026
ExpectedApril 10, 2025
April 1, 2025
2.5 years
July 20, 2021
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
metastasis rate
the incidence of gastric mesentery metastasis
an average of 1 year
Secondary Outcomes (3)
intraoperative complication
an average of 1 year
postoperative complication
an average of 1 year
3-year DFS
an average of 3 years
Eligibility Criteria
Patients hospitalized in the department of GI Surgery of Tongji Hospital
You may qualify if:
- Age between 18 and 75 years
- American Society of Anesthesiologists (ASA) score I to III
- A biopsy proven histological diagnosis of colorectal carcinoma
- Preoperative staging cT2-4aN0M0 or cTanyN+M0
- tumor located at hepatic flexure or transverse colon close to flexures
- Undergoing complete mesocolic excision with right gastric mesentery resection
- Patients have to be aware of the aim of the trial, and have signed the informed consent.
You may not qualify if:
- Synchronous colorectal carcinoma
- Clinical evidence of metastasis
- History of colorectal cancer or other malignant tumors
- Preoperative staging cT1N0 or cT4bNany
- Emergency procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jichao Qinlead
Study Sites (1)
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, 430030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 20, 2021
First Posted
July 28, 2021
Study Start
January 12, 2021
Primary Completion
July 19, 2023
Study Completion (Estimated)
July 19, 2026
Last Updated
April 10, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share